GE HealthCare Technologies Inc. (GEHC) Stock
GEHC has an Alpha Score of 47 out of 100 (weak), computed on Nov 6, 2026 from 3 of 4 sub-scores. 5 members of Congress disclosed 8 trades in GEHC since 2023: 3 purchases and 4 sales, most recently Alan Armstrong (purchase, Mar 27, 2026). 6 of the hedge funds AlphaScala tracks reported GEHC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Citadel's at $151.51M. Its trailing P/E ratio is 18.1 and its net margin 9.3% (key statistics as of Nov 4, 2026).
What is GEHC's Alpha Score?
How it works →Alpha Score of 47 reflects weak overall profile with strong momentum, poor value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 6, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded GE HealthCare Technologies Inc. (GEHC)?
Most recent: Alan Armstrong (purchase, Mar 27, 2026); records start Jan 4, 2023.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Alan Armstrong R-OK · Senate | 2026-03-27 | purchase | $1k – $15k |
| Terri Sewell D-AL · House | 2026-03-25 | sale | $1k – $15k |
| Warren Davidson R-OH · House | 2026-03-23 | sale | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-05-15 | purchase | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-04-08 | sale | $1k – $15k |
| Austin Scott R-GA · House | 2025-03-27 | sale | $1k – $15k |
| Rob Bresnahan R-PA · House | 2025-02-25 | purchase | $1k – $15k |
| Austin Scott R-GA · House | 2023-01-04 | exchange | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Nov 6, 2026.
See all GEHC political trades →Which hedge funds own GEHC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Citadel Ken Griffin | 2.37M | $151.51M | +83% |
| Point72 Steve Cohen | 1.17M | $74.63M | +832% |
| D.E. Shaw David Shaw | 418K | $26.76M | -11% |
| Millennium Management Israel Englander | 290K | $18.54M | +70% |
| Marshall Wace | 21K | $1.34M | -88% |
| Bridgewater Associates Ray Dalio | 16K | $998.2K | -78% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are GEHC's key statistics?
Key statistics as of Nov 4, 2026
How does GEHC's valuation compare with the Healthcare sector?
| Metric | GEHC | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 18.1 | 29.7 | 114 |
| Net margin | 9.33% | 3.62% | 174 |
| Return on equity | 18.90% | 2.96% | 200 |
| Dividend yield (payers) | 0.16% | 1.59% | 55 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 10, 2026). P/E excludes loss-making companies.
GEHC price chart
Powered by TradingViewWhat does GE HealthCare Technologies Inc. do?
GE HealthCare Technologies Inc. is a leading American health technology company headquartered in Chicago, Illinois. It specializes in advanced medical technologies, pharmaceutical diagnostics, and digital solutions across four key divisions: Imaging, which encompasses molecular imaging, computed tomography, magnetic resonance, women's health screening, and X-ray systems; Ultrasound; Patient Care Solutions, focusing on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, producing contrast agents and radiopharmaceuticals. The company serves hospitals and health networks globally, operating in over 100 countries with major facilities in regions including Europe, Asia, and India. GE HealthCare Technologies Inc. integrates AI, cloud, and software innovations to enhance precision diagnostics, patient monitoring, and care delivery, supporting providers in digitizing healthcare and improving efficiencies for health systems and researchers worldwide.